Concepedia

Bernard Hulin

BH

18

Publications

782

Citations

16

H-Index

1984

Active since

Affiliations

Pfizer (United States)(Current)

Sterling Research Group

Yale University

Bernard Hulin is an author at Pfizer (United States) specializing in biochemistry, chemistry, and natural sciences.

Top concepts

BiochemistryChemistryPharmacologyNatural SciencesMedicineEngineeringDrug DiscoveryOrganic ChemistryPharmacotherapyDrug Development

Publications per year

1984–2009

18

Publications

18

The epoxidation of unsaturated macrolides. Stereocontrolled routes to ionophore subunits

Stuart L. Schreiber, Tarek Sammakia, Bernard Hulin et al. · Journal of the American Chemical Society · 1986 · 103 citations

Biosynthesis, Engineering, Chemical Analysis +14

The Glitazone Family of Antidiabetic Agents

Bernard Hulin, Peter A. McCarthy, E. Michael Gibbs · Current Pharmaceutical Design · 1996 · 94 citations

Glucose Transport, Metabolic Syndrome, Biochemistry +15

Novel thiazolidine-2,4-diones as potent euglycemic agents.

Bernard Hulin, David A. Clark, Steven W. Goldstein et al. · Journal of Medicinal Chemistry · 1992 · 75 citations

Molecular Pharmacology, Medicinal Chemistry, Pharmaceutical Science +14

Substituted dihydrobenzopyran and dihydrobenzofuran thiazolidine-2,4-diones as hypoglycemic agents

David A. Clark, Steven W. Goldstein, R. A. VOLKMANN et al. · Journal of Medicinal Chemistry · 1991 · 66 citations

Effects of skyrin, a receptor-selective glucagon antagonist, in rat and human hepatocytes.

Jeremy C. Parker, R. Kirk McPherson, Kim Andrews et al. · Diabetes · 2000 · 63 citations · Full text

Cellular Pharmacology, Pharmacotherapy, Experimental Pharmacology +17

Rows per page

1–5 of 18